Brief: StenoCare And OWC Pharmaceutical Research To Enter Partnership To Develop Advanced Medical Cannabis Products

StenoCare A/S

13/11/2019 14:05

Nov 13 (Reuters) - StenoCare A/S  STENO.TE :
    * STENOCARE AND OWC PHARMACEUTICAL RESEARCH CORP. TO ENTER
PARTNERSHIP TO DEVELOP ADVANCED MEDICAL CANNABIS PRODUCTS
    * ("STENOCARE") AND OWC PHARMACEUTICAL RESEARCH CORP ("OWC")
HAVE
SIGNED A STRATEGIC MEMORANDUM OF UNDERSTANDING (MOU) TO DEVELOP
AND COMMERCIALIZE NEW CANNABIS-BASED MEDICAL PRODUCTS
    * IT IS EXPECTED THAT JOINTLY DEVELOPED PRODUCTS CAN BE
LAUNCHED,
SUBJECT TO OBTAINING RELEVANT APPROVALS AND LICENSES DURING 2021
AND 2022

Source text for Eikon:  ID:nWkr3jTvwr 
Further company coverage:  STENO.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))